Results

Total Results: 2,142 records

Showing results for "response".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - rates with corresponding dose, duration of response, remission, relapse, speed of response, time to … rates (with corresponding dose, duration of response, remission, relapse, speed of response time, time … Outcomes of interest Primary outcome: • Symptom response (e.g., behavioral issues, core features of … Secondary outcomes: • Response rates with corresponding dose, duration of response, remission, relapse … , speed of response, time to discontinuation of medication; • Growth (using BMI growth charts) and
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
    September 01, 2017 - Column 3 contains expert response to “is this conclusion still supported?” … Expert Response AHRQ assessment (comment) Disulfiram (Table D-2, Appendix D. … Expert Response AHRQ assessment (comment) moderate). … Expert Response AHRQ assessment (comment) drinking (SOE: low). … Expert Response AHRQ Assessment Disulfiram 1 study identified. SOE: Insufficient.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
    August 01, 2018 - placebo 3 RCT13-15 (n=1,047) 3 week Response Rate: Favors Cariprazine, OR 2.14 (95% CI 1.08, … placebo 5 RCT11, 16-19 (n=1199) 3 weeks Response Rate: Favors Olanzapine, OR 1.99 (95% CI 1.29, … placebo 4 RCT20-23 (n=1,007) 3 weeks Response Rate: Favors Quetiapine, OR 2.07 (95% CI 1.39, 3.09 … placebo 2 RCT25, 26 (n=584) 3 weeks Response Rate, YMRS, and CGI: Favors Risperidone (not pooled) … placebo 2 RCT27, 28 (n=402) 3 weeks Response Rate, YMRS, and CGI: Favors Ziprasidone (not pooled)
  4. effectivehealthcare.ahrq.gov/products/immunity-after-covid/protocol
    September 10, 2020 - Condition or Domain Being Studied Uncertainty exists regarding the immune response in individuals infected … Antibody development in response to infection (adaptive immunity) is only a part of the overall immune … response (also comprised of innate immunity), and there is limited understanding of the contribution … Do antibodies to SARS-CoV-2 confer active natural immunity (i.e. immunity due to acquired antibody response … Do antibodies to SARS-CoV-2 confer active natural immunity (i.e. immunity due to acquired antibody response
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
    July 26, 2012 - &productID=1199 Published Online: July 26, 2012 2 Commentator & Affiliation Section Comment Response … &productID=1199 Published Online: July 26, 2012 3 Commentator & Affiliation Section Comment Response … &productID=1199 Published Online: July 26, 2012 4 Commentator & Affiliation Section Comment Response … &productID=1199 Published Online: July 26, 2012 5 Commentator & Affiliation Section Comment Response … &productID=1199 Published Online: July 26, 2012 6 Commentator & Affiliation Section Comment Response
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-disposition-comments.pdf
    November 03, 2021 - research Published Online: November 3, 2021 2 Summary of Peer Reviewer Comments and Author Response … major-joint-replacement/research Published Online: November 3, 2021 3 Public Comments and Author Response
  7. Ebctandcfinal (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/ebctandcfinal.pdf
    June 05, 2012 - Evidence-Based Care (EBC) Challenge Terms and Conditions Terms and Conditions: By submitting a product in response … By submitting a product in response to the AHRQ Evidence-Based Care (EBC) Challenge, each team and
  8. effectivehealthcare.ahrq.gov/products/mental-illness-disparities/research-protocol
    June 06, 2015 - refer to access to accurate diagnosis, health care services, and treatment; quality of health care; and response … antipsychotics by veterans with schizophrenia have also been identified. 11 Gender differences in response … health care coverage; (c) improving quality of health care; and (d) improving adherence to treatment, response … health care, including health care coverage; (c) improving quality of health care; and (d) improving response … In instances where evidence from empirical studies informs the response, we will first provide a summary
  9. effectivehealthcare.ahrq.gov/sites/default/files/prehospital-airway-management-draft-appendix-f.xlsx
    June 22, 2020 - NR aOR BVM refererence 1.44 (1.03 to 2.03), NR Age, sex, witness, bystander CPR, shockable rhythm, response … districts NR BVM reference AOR 0.80 (0.43–1.48), NR Age, witness, bystander CPR, shockable rhythm, response … districts NR BVM reference AOR 1.46 (0.89–2.39), NR Age, witness, bystander CPR, shockable rhythm, response … NR aOR BVM refererence 1.98 (1.57 to 2.49), NR Age, sex, witness, bystander CPR, shockable rhythm, response … districts NR BVM reference AOR 1.49 (1.00–2.26), NR Age, witness, bystander CPR, shockable rhythm, response
  10. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-adult-patients-with-bipolar-disorder-including-bipolar-i-and-bipolar-ii-disorder-what-is-the-comparative-effectiveness-of-available-treatments-including-psychotherapy-other-psychosocial-treatments-medications-and-other-so
    April 22, 2013 - the combination of any of these medications For treatment of a manic episode following inadequate response … monotherapy vs. any mood-stabilizing medication For treatment of a depressive episode following inadequate response … Yes: Patients with inadequate response Patients with co-occurring substance use disorders Patients … Reduced impact of side effects of mood-stabilizing medications Note: Most studies have looked at "response
  11. effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
    June 16, 2010 - Dose may be modified depending on Hb response. … Dose may be modified depending on Hb response. … Dose may be modified depending on Hb response. *See also Background and Objectives. … Dose adaptation of erythropoietin depending on hematological response allowed. … be assessed and a clear definition of tumor response.  
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - Dose may be modified depending on Hb response. … Dose may be modified depending on Hb response. … Dose may be modified depending on Hb response. *See also Background and Objectives. … Dose adaptation of erythropoietin depending on hematological response allowed. … will be assessed and a clear definition of tumor response.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research-protocol.pdf
    November 24, 2014 - Several recent studies have highlighted differences in response to pharmacotherapy based on baseline … to two types of antidepressants (imipramine or paroxetine) begins to outpace placebo response only … Outcomes • Efficacy: response, remission, speed of response, speed of remission, relapse, quality … to SGA • Response/ remission • Speed of response/ remission Source: www.effectivehealthcare.ahrq.gov … Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - The response is organized around the following review questions: 1.3 Review Questions 1. … For this rapid response, strategic adjustments were made to streamline traditional systematic review … Discussion 4.1 Interpretation of Findings The findings of the rapid response indicate that active … https://www.cdc.gov/hai/pdfs/mdro- guides/Health-Response-Contain-MDRO- 508.pdf. … Search and contain: Impact of an integrated genomic and epidemiological surveillance and response
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/grading-quiz.ppt
    September 02, 2013 - Dose-response association, plausible confounders, strength of association, and publication bias Plausible … The correct other domains are dose-response association, plausible confounders, strength of association … The correct other domains are dose-response association, plausible confounders, strength of association
  16. effectivehealthcare.ahrq.gov/sites/default/files/grading-quiz.ppt
    September 02, 2013 - Dose-response association, plausible confounders, strength of association, and publication bias Plausible … The correct other domains are dose-response association, plausible confounders, strength of association … The correct other domains are dose-response association, plausible confounders, strength of association
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-reviews-end-user_white-paper.pdf
    April 01, 2016 - Taxonomy of rapid products: Rapid Response………………………………….. 11 Figure 4. … Uses of rapid products and standard systematic reviews Use Evidence Inventory Rapid Response Rapid … Taxonomy of rapid products: Rapid Response8 Rapid Response: Again, few KIs found this product to … Cochrane Response - the new Rapid Review from Cochrane. 2014. … Rapid Response Sample Knee-length versus Thigh-length Compression Devices for Treating Deep Venous
  18. effectivehealthcare.ahrq.gov/products/hepatitis-c/research
    November 27, 2012 - ribavirin, and either boceprevir or telaprevir that reported clinical outcomes, sustained virologic response … effectiveness in patient subgroups defined by demographic or clinical characteristics, although absolute response
  19. effectivehealthcare.ahrq.gov/products/glaucoma/abstract
    November 09, 2011 - Objectives: To compare the proportion of patients who achieve a successful response to treatment (reduction … at 1-year post-treatment initiation To compare the proportion of patients who achieve a successful response
  20. effectivehealthcare.ahrq.gov/sites/default/files/cer-232-breathlessness-cancer-comments.pdf
    November 19, 2020 - dyspnea-advanced-cancer/report Published Online: November 19, 2020 2 Commentator & Affiliation Section Comment Response … dyspnea-advanced-cancer/report Published Online: November 19, 2020 7 Commentator & Affiliation Section Comment Response … dyspnea-advanced-cancer/report Published Online: November 19, 2020 8 Commentator & Affiliation Section Comment Response … dyspnea-advanced-cancer/report Published Online: November 19, 2020 9 Commentator & Affiliation Section Comment Response … original statement was based on the written text portion of the guideline which is what NCCN provided in response

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: